Hepatitis B virus (HBV) or hepatitis C virus (HCV) infections can lead to cirrhosis as well as liver cancer.A recent study on Hepatology from Taiwan has found statin drugs to be beneficial in patients with HBV- or HCV-related cirrhosis.
When the liver fails to compensate for the functional overload resulting from disease, a situation called decompensation occurs. Decompensation significantly lowers the survival rate among patients with cirrhosis, and very few effective drugs are available.
This latest study assessed information on 1350 cirrhotic patients identified from a representative group of Taiwan National Health Insurance beneficiaries from 2000 to 2013. Statin use was linked with a decreased risk of decompensation in a dose-dependent manner.